A company called ASML makes machines that help create tiny parts inside computers and phones. They didn't do very well last year, but some people think they will do much better this year. A man from a big bank named Cantor Fitzgerald says the stock is worth more than what it costs now, so if you buy it, you might make money when it goes up. He thinks it can go up by 21%. Read from source...

1. The title of the article is misleading and sensationalized. It claims that ASML is a top analyst pick with 21% upside ahead of Q4 earnings, but it does not mention any specific analyst or their credentials. This creates a false impression that the author has some insider knowledge or access to exclusive information.
2. The article compares ASML's performance to other SPE peers, such as Applied Materials, Lam Research, and KLA Corp, without providing any context or explanation for why these companies are relevant or how they affect ASML's prospects. This creates a biased impression that ASML is underperforming and needs to catch up with its competitors, rather than highlighting its unique strengths and advantages.
3. The article cites Cantor Fitzgerald as the source of the Overweight rating and €900 price target, but it does not disclose any potential conflicts of interest or incentives that the analyst may have to promote ASML stock. This creates a suspicion that the author is either paid by or affiliated with Cantor Fitzgerald, or that they are simply parroting their opinion without critical evaluation.
4. The article uses vague and ambiguous terms such as "orders", "bookings", "peak", "decline", "outlook", and "reversal" to describe ASML's performance and prospects, without providing any concrete data or evidence to support these claims. This creates a sense of uncertainty and speculation, rather than confidence and conviction.
5. The article introduces the concept of "FIFO" as an attractive investment thesis, but it does not explain what it means or how it applies to ASML's situation. It also does not address any potential risks or challenges that ASML may face in the near or long term, such as regulatory issues, supply chain disruptions, technological innovation, or market competition. This creates a one-sided and incomplete view of ASML's investment case, rather than a balanced and comprehensive analysis.